Google's Gemini 2.0 rolls out to everyone to compete with OpenAI, Microsoft, and DeepSeek
Google's Gemini 2.0 just rolled out to everyone. The tech giant has several models that compete with trending tech from ...
BioSpace19h
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
The Chemical Engineer20h
FDA approves ‘first’ of new class of non-addictive drugs for severe pain
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
Zacks.com on MSN21h
CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?
CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...